{
    "clinical_study": {
        "@rank": "159653", 
        "arm_group": [
            {
                "arm_group_label": "Western therapy & Placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "Western therapy(oral care, skin care and reducing temperature) Placebo for JET(Jinlianqingre Effervescent Tablets )"
            }, 
            {
                "arm_group_label": "Western therapy & JET", 
                "arm_group_type": "Experimental", 
                "description": "Jinlianqingre Effervescent Tablets plus western therapy"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is aimed to evaluate the effectiveness and safety of Jinlianqingre Effervescent\n      Tablets, a traditional Chinese medicine (TCM), in the treatment of Uncomplicated hand, foot,\n      and mouth disease (HFMD)."
        }, 
        "brief_title": "Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study", 
        "completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "condition": "Hand, Foot and Mouth Disease", 
        "condition_browse": {
            "mesh_term": [
                "Foot-and-Mouth Disease", 
                "Hand, Foot and Mouth Disease", 
                "Mouth Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "By adopting a multicenter, prospective, randomized double-blind, placebo-controlled, this\n      study is aimed to evaluate the effectiveness, safety of a traditional Chinese medicine,\n      Jinlianqingre Effervescent Tablets, for treatment Uncomplicated HFMD, and to provide\n      scientific evidence for the construction of TCM methods in treating HFMD."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of mild hand-foot-mouth disease patients according to\n             Hand-Foot-Mouth Disease Treatment Guidelines 2010 issued by China's Ministry of\n             Health;\n\n          -  Within 48 hours of onset of fever and rash symptom.\n\n          -  Age of 1-13 years.\n\n          -  Documented body temperature 37.4 \u00b0C-39.0\u00b0C\n\n          -  Patients or their guardians agree to participate in this study and signed the\n             informed consent form.\n\n        Exclusion Criteria:\n\n          -  Complicated with other serious diseases such as chronic hepatitis,chronic diarrhea\n             disease,chronic diarrhea, congenital heart disease, acute or chronic nephritis and\n             blood diseases.\n\n          -  With history of allergies on traditional Chinese medicine.\n\n          -  Attending other clinical studies on HFMD after diagnosed."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "13 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "288", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01769794", 
            "org_study_id": "ChinaACMS-HFMD"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Western therapy & Placebo", 
                    "Western therapy & JET"
                ], 
                "description": "Physical cooling paste or warm bathing, vitamin B, vitamin C. On the basis of the attending physician's judgment, participants were allowed to use Ibuprofen suspension if their body temperature was greater than 38.5\u2103. Likewise, the need for antibiotics was determined by the attending physicians. The use of acetaminophen or antibiotics was recorded on the case record form", 
                "intervention_name": "Western therapy", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Western therapy & JET", 
                "description": "4g/tablet, One tablet each time (Taken after dissolved in 50ml boiled water, 3 times daily if body temperature\u226538.5\u2103)", 
                "intervention_name": "JET", 
                "intervention_type": "Drug", 
                "other_name": "Jinlianqingre Effervescent Tablets"
            }, 
            {
                "arm_group_label": "Western therapy & Placebo", 
                "description": "placebos prepared identical in color, taste and consistency to the JET (supplied by Zhongshenghaitian Pharmaceutical, Tianjin, China)", 
                "intervention_name": "Placebo(for JET)", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hand, Foot and Mouth Disease", 
            "Medicine, Chinese Traditional", 
            "Enterovirus", 
            "Fever"
        ], 
        "lastchanged_date": "January 16, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tangshan", 
                        "country": "China", 
                        "state": "Hebei", 
                        "zip": "063020"
                    }, 
                    "name": "Tangshan infectious disease hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610072"
                    }, 
                    "name": "Affiliated Hospital of Chengdu university of Traditional Chinese Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100045"
                    }, 
                    "name": "Beijing children's hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China", 
                        "zip": "300192"
                    }, 
                    "name": "Tianjin infectious disease hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "overall_official": [
            {
                "affiliation": "China  Academy of Chinese Medical Sciences", 
                "last_name": "Boyan Liu, chief physician", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine", 
                "last_name": "Guoliang Zhang, chief", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: State Administration of Traditional Chinese Medicine of the People's Republic of China", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Referring to the time of the armpit temperature of lower than 37.0 degrees Celsius, lasting for at least 24 hours, after the medicine is taken.", 
            "measure": "The time of body temperature going back to normal", 
            "safety_issue": "Yes", 
            "time_frame": "10 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01769794"
        }, 
        "responsible_party": {
            "investigator_affiliation": "China  Academy of Chinese Medical Sciences", 
            "investigator_full_name": "Liyun He", 
            "investigator_title": "chief", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Referring to the number of days in the total-contact cast until the skin completely closed after the medicine is used.", 
                "measure": "Healing time of skin or oral mucosa lesions symptom", 
                "safety_issue": "Yes", 
                "time_frame": "10 days"
            }, 
            {
                "description": "Referring to Symptoms were hands, feet, oral mucosa lesions, buttock, crissum, back and four limbs. Each symptom was scored as 0 (none), 1 (mild), 2 (modest), or 3 (severe).", 
                "measure": "Score of skin or oral mucosa lesions symptom during the study period time", 
                "safety_issue": "Yes", 
                "time_frame": "10 days"
            }, 
            {
                "measure": "the length of hospital stay", 
                "safety_issue": "Yes", 
                "time_frame": "10 days"
            }, 
            {
                "description": "Referring to pulmonary edema, cardiac damage, pneumonia, secondary infection, meningitis, encephalomyelitis et al.", 
                "measure": "major complications rate", 
                "safety_issue": "Yes", 
                "time_frame": "10 days"
            }
        ], 
        "source": "China  Academy of Chinese Medical Sciences", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Chengdu University of Traditional Chinese Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Beijing Children's Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Tianjin infectious disease hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Tangshan infectious disease hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Tianjin Zhongshenghaitian Pharmaceutical Co. Ltd.", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "China  Academy of Chinese Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}